FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Graefen

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Co-author Network

Publications

TOP 3
Massimo Lazzeri; Philippe Le Corvoisier; Giovanni Lughezzani; Thomas McNicholas; Joan Palou Redorta; Vincenzo Scattoni; Amy Sussman; Alexander Haese; Josep Alberola Bou; Vittorio Bini; Alexandre de la Taille; Salvador Esquena Fernández; Massimo Freschi; Bijan Ghaleh; Markus Graefen; Giorgio Guazzoni
Reply from Authors re: Stacy Loeb. Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker? Eur Urol 2013;63:995-6.
Massimo Lazzeri; Philippe Le Corvoisier; Giovanni Lughezzani; Thomas McNicholas; Joan Palou Redorta; Vincenzo Scattoni; Amy Sussman; Alexander Haese; Josep Alberola Bou; Vittorio Bini; Alexandre de la Taille; Salvador Esquena Fernández; Massimo Freschi; Bijan Ghaleh; Markus Graefen; Giorgio Guazzoni
Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study.
Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Graefen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Massimo Lazzeri; Philippe Le Corvoisier; Giovanni Lughezzani; Thomas McNicholas; Joan Palou Redorta; Vincenzo Scattoni; Amy Sussman; Alexander Haese; Josep Alberola Bou; Vittorio Bini; Alexandre de la Taille; Salvador Esquena Fernández; Massimo Freschi; Bijan Ghaleh; Markus Graefen; Giorgio Guazzoni
Reply from Authors re: Stacy Loeb. Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker? Eur Urol 2013;63:995-6.
European urology 2013;63(6):996-7.
2013: Massimo Lazzeri; Philippe Le Corvoisier; Giovanni Lughezzani; Thomas McNicholas; Joan Palou Redorta; Vincenzo Scattoni; Amy Sussman; Alexander Haese; Josep Alberola Bou; Vittorio Bini; Alexandre de la Taille; Salvador Esquena Fernández; Massimo Freschi; Bijan Ghaleh; Markus Graefen; Giorgio Guazzoni
Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study.
European urology 2013;63(6):986-94.
2013: Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.
Annals of surgical oncology 2013;20(6):2096-102.
2013: Lia Burkhardt; Sarah Fuchs; Markus Graefen; Hartwig Huland; Martina Kluth; Antje Krohn; Malte Mader; Sawinee Masser; Sarah Minner; Guido Sauter; Thorsten Schlomm; Hüseyin Sirma; Thomas Steuber; Frederik Bachmann; Ronald Simon
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer.
Cancer research 2013;73(9):2795-805.
2013: Markus Graefen; Thorsten Schlomm
Active surveillance for low-risk prostate cancer: some questions are answered, but many questions remain.
European urology 2013;63(4):604-5.
2013: Alberto Briganti; Felix K-H Chun; Bruno Frea; Detlef Frohenberg; Simone Giona; Massimiliano Di Marco; Markus Graefen; R Jeffrey Karnes; Steven Joniau; Pierre I Karakiewicz; Burkhard Kneitz; Giansilvio Marchioro; Francesco Montorsi; Martin Spahn; Maxine Sun; Hein Van Poppel; Firas Abdollah; Marco Bianchi
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
European urology 2013;63(4):693-701.
2013: Julia Müller; Guido Sauter; Thorsten Schlomm; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Lia Burkhardt; Arne Ehlers; Markus Graefen; Sarah Minner; Uwe Michl
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.
International journal of cancer. Journal international du cancer 2013;132(6):1333-40.
2013: Jens Hansen; Michael Rink; Shahrokh Shariat; Markus Graefen; Felix K-H Chun
Assays for prostate cancer : changing the screening paradigm?
Molecular diagnosis & therapy 2013;17(1):1-8.
2013: Markus Graefen; Thorsten Schlomm
From diagnostic tool to disease monitoring: the growing role of prostate biopsies.
European urology 2013;63(2):231-3.
2013: Jens Hansen; Hartwig Huland; Michael Marberger; Leonard S Marks; Peter F A Mulders; Alan W Partin; Karl Pummer; Jack A Schalken; Shahrokh F Shariat; Arnulf Stenzl; Hendrik van Poppel; Jochen Walz; Clement-Claude Abbou; Sascha A Ahyai; Marco Auprich; Alberto Briganti; Alexandre de la Taille; William Ellis; Margit Fisch; Yves Fradet; Markus Graefen; Alexander Haese; fianceeyi chun
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
European urology 2013;63(2):201-9.
2013: Sarah Minner; Georg Salomon; Guido Sauter; Thorsten Schlomm; Ronald Simon; Melanie Bauer; Carsten Bokemeyer; Fabian Freudenthaler; Michael Gärtner; Markus Graefen; Hans Heinzer; Martina Kluth; Waldemar Wilczak
Marked heterogeneity of ERG expression in large primary prostate cancers.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(1):106-16.
2013: Georg Salomon; Mareike Sandmann; Thorsten Schlomm; Jan Spethmann; Philippe Autier; Ann Beckmann; Leopold Durner; Markus Graefen; Alexander Haese; Hans Heinzer; Uwe Michl; Caroline Moore; Thomas Steuber
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomy.
BJU international 2013;111(1):60-6.
2013: Jens Hansen; Pierre I Karakiewicz; Luis A Kluth; Michael Rink; Shahrokh F Shariat; Thomas Steuber; Zhe Tian; Sascha A Ahyai; Marco Bianchi; Alberto Briganti; Margit Fisch; Markus Graefen; Felix K-H Chun
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
The Prostate 2013;73(2):211-8.
2012: Lars Budäus; Felix K-H Chun; Margit Fisch; Alexander Haese; Hans Heinzer; Hartwig Huland; Hendrik Isbarn; Uwe Michl; Georg Salomon; Thorsten Schlomm; Thomas Steuber; Pierre Tennstedt; Markus Graefen
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
BJU international 2012;110(11):1714-20.
2012: Lars Budäus; Markus Graefen; Hartwig Huland
Controversies in the management of localized prostate cancer: radical prostatectomy still the standard of care.
Critical reviews in oncology/hematology 2012;84 Suppl 1():e24-9.
2012: Philipp Schriefer; Stefan Steurer; Hartwig Huland; Markus Graefen
Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):e341-4.
2012: Stefan T Börno; Jan C Brase; Rainer Claus; Andreas Dahl; Francesca Demichelis; Maria Fälth; Axel Fischer; Markus Graefen; Christina Grimm; Melanie Isau; Martin Kerick; Rohini Kuner; Mark Laible; Hans Lehrach; Christoph Plass; Christina Röhr; Mark A Rubin; Guido Sauter; Behnam Sayanjali; Thorsten Schlomm; Ronald Simon; Holger Sültmann; Bernd Timmermann; Andrea Wunderlich; Michal R Schweiger
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation.
Cancer discovery 2012;2(11):1024-35.
2012: J Schmitges; Q-D Trinh; L Budäus; Markus Graefen; Hans Heinzer; Hartwig Huland; L Jonas; Pierre I Karakiewicz; R Larbig; Thorsten Schlomm; Thomas Steuber
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(11):1082-8.
2012: Bernardo Rocco; Matteo G Spinelli; Ashutosh Tewari; Peter Wiklund; Walter Artibani; Rafael Ferreira Coelho; Gabriele Cozzi; Franco Gaboardi; Inderbir S Gill; Markus Graefen; Francesco Montorsi; Alex Mottrie; Vipul R Patel; Francesco Rocco
Posterior musculofascial reconstruction after radical prostatectomy: a systematic review of the literature.
European urology 2012;62(5):779-90.
2012: Jens Hansen; Hans Heinzer; Hartwig Huland; Michael Rink; Georg Salomon; Thorsten Schlomm; Jan Spethmann; Thomas Steuber; Lars Budäus; Markus Graefen; Alexander Haese; Uwe Michl
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
Urology 2012;80(4):877-82.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Markus Graefen; Jens Hansen; Francesco Montorsi; Paul Perrotte; Jesse Sammon; Shahrokh F Shariat; Pierre I Karakiewicz
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.
European urology 2012;62(4):696-703.
2012: Giacomo Novara; Raymond C Rosen; Shahrokh F Shariat; Jens-Uwe Stolzenburg; Hendrik Van Poppel; Filiberto Zattoni; Walter Artibani; Anthony Costello; James A Eastham; Vincenzo Ficarra; Markus Graefen; Giorgio Guazzoni; Francesco Montorsi; Alexandre Marie Mottrie; Timothy G Wilson
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy.
European urology 2012;62(3):431-52.
2012: Giacomo Novara; Vipul R Patel; Raymond C Rosen; Shahrokh F Shariat; Ashutosh K Tewari; Hendrik Van Poppel; Filiberto Zattoni; Thomas E Ahlering; Peter R Carroll; Vincenzo Ficarra; Markus Graefen; Giorgio Guazzoni; Mani Menon; Simone Mocellin; Francesco Montorsi; Alexandre Marie Mottrie; Timothy G Wilson
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.
European urology 2012;62(3):382-404.
2012: Vincenzo Ficarra; Markus Graefen; Giorgio Guazzoni; Mani Menon; Thomas E Ahlering; Anthony Costello; James A Eastham; Alexandre Marie Mottrie; Giacomo Novara; Vipul R Patel; Raymond C Rosen; Ashutosh K Tewari; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Francesco Montorsi
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.
European urology 2012;62(3):418-30.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Mani Menon; Francesco Montorsi; Paul Perrotte; Marco Bianchi; Felix K Chun; Roland Dahlem; Margit Fisch; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
BJU international 2012;110(6 Pt B):E183-90.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Mani Menon; Francesco Montorsi; Paul Perrotte; Georg Salomon; Thorsten Schlomm; Pierre I Karakiewicz
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
BJU international 2012;110(6):828-33.
2012: Marco Bianchi; Alberto Briganti; Markus Graefen; Claudio Jeldres; Mani Menon; Malek Meskawi; Francesco Montorsi; James O Peabody; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Pierre I Karakiewicz
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2012;6(4):245-50.
2012: Antje Krohn; Stefan Kurtz; Malte Mader; Pascale-Sophie Mayer; Marie Meyer-Kornblum; Sarah Minner; Christoph Plass; Fred Saad; Guido Sauter; Lia Burkhardt; Colin De Silva; Tobias Diedler; Clarissa Gerhäuser; Markus Graefen; Joseph Huang; Darja Kötschau; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Pierre Tennstedt; Thorsten Schlomm
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.
The American journal of pathology 2012;181(2):401-12.
2012: Jens Hansen; Marco Bianchi; Felix K-H Chun; Markus Graefen; Nawar Hanna; Malek Meskawi; Paul Perrotte; Michael Rink; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
Urology 2012;80(2):347-53.
2012: Thorsten Schlomm; Thomas Steuber; Stefan Steurer; Pierre Tennstedt; Corinna Wittmer; Lars Budäus; Markus Graefen; Alexander Haese; Jens Hansen; Hans Heinzer; Caroline Huxhold; Uwe Michl; Sarah Minner; Georg Salomon; Guido Sauter; Hartwig Huland
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.
European urology 2012;62(2):333-40.
2012: Andrea Salonia; Arthur L Burnett; Markus Graefen; Kostas Hatzimouratidis; Francesco Montorsi; John P Mulhall; Christian Stief
Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function.
European urology 2012;62(2):273-86.
2012: Andrea Salonia; Arthur L Burnett; Markus Graefen; Kostas Hatzimouratidis; Francesco Montorsi; John P Mulhall; Christian Stief
Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery.
European urology 2012;62(2):261-72.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Does partial nephrectomy at an academic institution result in better outcomes?
World journal of urology 2012;30(4):505-10.
2012: J Schmitges; M Sun; Q-D Trinh; F Abdollah; M Bianchi; L Budäus; F K Chun; Markus Graefen; H Isbarn; Pierre I Karakiewicz; Thorsten Schlomm; Thomas Steuber
Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(7):624-9.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1503-11.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
BJU international 2012;110(2 Pt 2):E21-7.
2012: Jan Schmitges; Shahrokh F Shariat; Thomas Steuber; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Sascha A Ahyai; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
International urology and nephrology 2012;44(3):799-806.
2012: Phillip R Stahl; Pierre Tennstedt; Markus Graefen; Jakob Izbicki; Adisa Kilgué; Geeske V Krause; Antje Krohn; Sarah Minner; Guido Sauter; Thorsten Schlomm; Ronald Simon; Waldemar Wilczak
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.
The Prostate 2012;72(8):898-903.
2012: Maxine Sun; Zhe Tian; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Daniel Pharand; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
BJU international 2012;109(12):1807-12.
2012: Marco Auprich; Lars Budäus; Herbert Augustin; Margit Fisch; Markus Graefen; Luis Kluth; Sebastian Mannweiler; Karl Pummer; Shahrokh F Shariat; fianceeyi chun
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
BJU international 2012;109(11):1627-35.
2012: Daher C Chade; James Eastham; Markus Graefen; Jim C Hu; R Jeffrey Karnes; Laurence Klotz; Francesco Montorsi; Peter T Scardino; Hendrik van Poppel; Shahrokh F Shariat
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
European urology 2012;61(5):961-71.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Open radical prostatectomy in the elderly: a case for concern?
BJU international 2012;109(9):1335-40.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Christian Eichelberg; Markus Graefen; Jens Hansen; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
Urology 2012;79(4):796-803.
2012: Nawar Hanna; Jens Hansen; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.
European urology 2012;61(4):715-21.
2012: Stephen A Boorjian; James A Eastham; Markus Graefen; Bertrand Guillonneau; R Jeffrey Karnes; Judd W Moul; Edward M Schaeffer; Christian Stief; Kevin C Zorn
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
European urology 2012;61(4):664-75.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Morbidity and mortality of radical prostatectomy differs by insurance status.
Cancer 2012;118(7):1803-10.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
Cancer 2012;118(7):1894-900.
2012: Alberto Briganti; Bruno Frea; Detlef Frohneberg; Massimiliano Di Marco; Markus Graefen; Steven Joniau; R Jeffrey Karnes; Burkhard Kneitz; Giansilvio Marchioro; Francesco Montorsi; Niccolò M Passoni; Alessandro Tizzani; Bertrand Tombal; Hein Van Poppel; Jochen Walz; Firas Abdollah; Chris H Bangma; Martin Spahn
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
European urology 2012;61(3):584-92.
2012: Jan Schmitges; Maxine Sun; Quoc-Dien Trinh; Paul Perrotte; Thorsten Schlomm; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
Urology 2012;79(2):332-8.
2012: Hein van Poppel; Mesut Remzi; Alexandre de la Taille; Theo de Reijke; Markus Graefen; Alexander Haese; Jacques Irani; Michael Marberger
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
BJU international 2012;109(3):360-6.
2012: John M Fitzpatrick; Markus Graefen; Heather A Payne; Florian Scotté; Matti S Aapro
A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.
The oncologist 2012;17 Suppl 1():31-5.
2012: Markus Graefen; Thorsten Schlomm
Is radical prostatectomy a useful therapeutic option for high-risk prostate cancer in older men?
The oncologist 2012;17 Suppl 1():4-8.
2012: Maria Schubert; Bertrand Tombal; Paul van Cangh; Hein van Poppel; Jochen Walz; Pia Bader; Chris Bangma; Alberto Briganti; Detlef Frohneberg; Paolo Gontero; Markus Graefen; Chao-Yu Hsu; Steven Joniau; R Jeffrey Karnes; Burkhard Kneitz; Susanne Kneitz; Giansilvio Marchioro; Claus-Jürgen Scholz; Fritz Schröder; Martin Spahn
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.
Advances in urology 2012;2012():612707.
2012: Bobby B Najari; Michael Rink; Shahrokh F Shariat; Markus Graefen; Felix K Chun
Does low-risk prostate cancer detection change with repeat biopsies?
European urology 2012;61(1):230-1.
2012: Pierre Tennstedt; Thomas Steuber; Andreas Brüchmann; Markus Graefen; Alexander Haese; Hartwig Huland; Patricia Köster; Sarah Minner; Martina Mirlacher; Guido Sauter; Thorsten Schlomm; Ronald Simon
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
International journal of oncology 2012;40(1):261-8.
2011: Sarah Minner; Guido Sauter; Michael Tachezy; Waldemar Wilczak; Carsten Bokemeyer; Markus Graefen; Hartwig Huland; Ergin Kilic; Franziska Kraetzig; Thorsten Schlomm
Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
Human pathology 2011;42(12):1946-52.
2011: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
The Journal of urology 2011;186(5):1849-54.
2011: Lars Budäus; Margit Fisch; Markus Graefen; Alexander Haese; Hans Heinzer; Hartwig Huland; Hendrik Isbarn; Georg Salomon; Thorsten Schlomm; Jan Schmitges; Jan Spethmann; Laura Beesch; Thomas Steuber
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.
BJU international 2011;108(8):1256-61.
2011: Sarah Minner; Julia Müller; Klaus Pantel; Guido Sauter; Hartmut Schlüter; Laura Scholz; Udo Schumacher; Ronald Simon; Hüseyin Sirma; Thomas Steuber; Pierre Tennstedt; Carsten Bokemeyer; Jan C Brase; Malaika Enodien; Markus Graefen; Antje Krohn; Alvin Y Liu; Andreas M Luebke; Pascale S Mayer; Thorsten Schlomm
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(18):5878-88.
2011: Firas Abdollah; Orchidee Djahangirian; Markus Graefen; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
The Journal of urology 2011;186(3):824-8.
2011: Lars Budäus; Markus Graefen; Alexander Haese; Hendrik Isbarn; Rupinder Johal; Firas Abdollah; Giovanni Lughezzani; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Kevin C Zorn; Pierre I Karakiewicz
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
BJU international 2011;108(6):888-93.
2011: Jan Schmitges; Quoc-Dien Trinh; Jochen Walz; Markus Graefen
Surgery for high-risk localized prostate cancer.
Therapeutic advances in urology 2011;3(4):173-82.
2011: Markus Graefen
Salvage radical prostatectomy in 2011: an established therapeutic option?
European urology 2011;60(2):211-3.
2011: Thorsten Schlomm; Thomas Steuber; Uwe Michl; Georg Salomon; Oliver Engel; Markus Graefen; Alexander Haese; Hans Heinzer; Hartwig Huland
Full functional-length urethral sphincter preservation during radical prostatectomy.
European urology 2011;60(2):320-9.
2011: Alexandre de la Taille; Jacques Irani; Markus Graefen; Felix Chun; Theo de Reijke; Paul Kil; Paolo Gontero; Alain Mottaz; Alexander Haese
Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.
The Journal of urology 2011;185(6):2119-25.
2011: Thomas Steuber; Lars Budäus; Jochen Walz; Kevin C Zorn; Thorsten Schlomm; fianceeyi chun; Sascha A Ahyai; Margit Fisch; Guido Sauter; Hartwig Huland; Markus Graefen; Alexander Haese
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
BJU international 2011;107(11):1755-61.
2011: L Budäus; M Morgan; F Abdollah; K C Zorn; M Sun; R Johal; R Thuret; A Abdo; J Schmitges; H Isbarn; Claudio Jeldres; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(5):429-34.
2011: Jochen Walz; Markus Graefen; Hartwig Huland
Surgical anatomy of the prostate in the era of radical robotic prostatectomy.
Current opinion in urology 2011;21(3):173-8.
2011: Jin Yamamura; Georg Salomon; Ralph Buchert; Arne Hohenstein; Joachim Graessner; Hartwig Huland; Markus Graefen; Gerhard Adam; Ulrike Wedegaertner
Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy.
Journal of computer assisted tomography 2011;35(2):223-8.
2011: Daniel Liberman; Giovanni Lughezzani; Maxine Sun; Ahmed Alasker; Rodolphe Thuret; Firas Abdollah; Lars Budaus; Hugues Widmer; Markus Graefen; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Urology 2011;77(3):660-6.
2011: Firas Abdollah; Lars Budäus; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Alexander Haese; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.
The Journal of urology 2011;185(3):855-61.
2011: Lars Budäus; Maxine Sun; Firas Abdollah; Kevin C Zorn; Monica Morgan; Rupinder Johal; Daniel Liberman; Rodolphe Thuret; Hendrik Isbarn; Georg Salomon; Alexander Haese; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.
Annals of surgical oncology 2011;18(3):839-47.
2011: Jochen Walz; Steven Joniau; fianceeyi chun; Hendrik Isbarn; Claudio Jeldres; Ofer Yossepowitch; Hsu Chao-Yu; Eric A Klein; Peter T Scardino; Alwyn M Reuther; Hein Van Poppel; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
BJU international 2011;107(5):765-70.
2011: Daniel Liberman; Ahmed Alasker; Maxine Sun; Salima Ismail; Giovanni Lughezzani; Claudio Jeldres; Lars Budaus; Rodolphe Thuret; Shahrokh F Shariat; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
BJU international 2011;107(6):905-11.
2011: Sarah Minner; Corinna Wittmer; Markus Graefen; Georg Salomon; Thomas Steuber; Alexander Haese; Hartwig Huland; Carsten Bokemeyer; Emre F Yekebas; Judith Dierlamm; Stefan Balabanov; Ergin Kilic; Waldemar Wilczak; Ronald Simon; Guido Sauter; Thorsten Schlomm
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
The Prostate 2011;71(3):281-8.
2011: Marco Auprich; fianceeyi chun; John F Ward; Karl Pummer; Richard Babaian; Herbert Augustin; Ferdinand Luger; Stefan Gutschi; Lars Budäus; Margit Fisch; Hartwig Huland; Markus Graefen; Alexander Haese
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
European urology 2011;59(1):96-105.
2010: Lars Budäus; Firas Abdollah; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
The Journal of urology 2010;184(6):2285-90.
2010: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Lars Budäus; Claudio Jeldres; Markus Graefen; Alberto Briganti; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
European urology 2010;58(6):882-92.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Ahmed Alasker; Claudio Jeldres; Hendrik Isbarn; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; François Bénard; Fred Saad; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
International journal of radiation oncology, biology, physics 2010;78(5):1307-13.
2010: Marco Auprich; Alexander Haese; Jochen Walz; Karl Pummer; Alexandre de la Taille; Markus Graefen; Theo de Reijke; Margit Fisch; Paul Kil; Paolo Gontero; Jacques Irani; fianceeyi chun
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.
European urology 2010;58(5):727-32.
2010: Anja Mehnert; C Lehmann; Markus Graefen; Hartwig Huland; Uwe Koch
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients.
European journal of cancer care 2010;19(6):736-45.
2010: Maxime Crépel; Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Ahmed Alasker; umberto capitanio; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Urology 2010;76(4):883-8.
2010: Lars Budäus; Markus Graefen; Georg Salomon; Hendrik Isbarn; Giovanni Lughezzani; Maxine Sun; Felix K H Chun; Thorsten Schlomm; Thomas Steuber; Alexander Haese; Jens Koellermann; Guido Sauter; Margit Fisch; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
International journal of urology : official journal of the Japanese Urological Association 2010;17(10):862-8.
2010: Lars Budäus; Hendrik Isbarn; Christian Eichelberg; Giovanni Lughezzani; Maxine Sun; Paul Perrotte; fianceeyi chun; Georg Salomon; Thomas Steuber; Jens Köllermann; Guido Sauter; Sascha A Ahyai; Mario Zacharias; Margit Fisch; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
The Journal of urology 2010;184(4):1341-6.
2010: Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Shahrokh F Shariat; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Cancer 2010;116(16):3774-84.
2010: Bob Djavan; Peter Schlegel; Georg Salomon; Elisabeth Eckersberger; Helen Sadri; Markus Graefen
Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancer.
The Canadian journal of urology 2010;17(4):5265-71.
2010: Sascha A Ahyai; Mario Zacharias; Hendrik Isbarn; Thomas Steuber; Christian Eichelberg; Jens Köllermann; Margit Fisch; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen; fianceeyi chun
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
BJU international 2010;106(4):478-83.
2010: Hendrik Isbarn; Manuela Wanner; Georg Salomon; Thomas Steuber; Thorsten Schlomm; Jens Köllermann; Guido Sauter; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
BJU international 2010;106(1):37-43.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Susanne Vogel; Claudio Jeldres; Giovanni Lughezzani; Alberto Briganti; Francesco Montorsi; Paul Perrotte; Sascha A Ahyai; Lars Budäus; Christian Eichelberg; Roman Heuer; Jens Köllermann; Guido Sauter; Thorsten Schlomm; Thomas Steuber; Alexander Haese; Mario Zacharias; Margit Fisch; Hans Heinzer; Hartwig Huland; fianceeyi chun; Markus Graefen
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
International journal of radiation oncology, biology, physics 2010;77(3):784-7.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Jochen Walz; Sascha A Ahyai; Thomas Steuber; Alexander Haese; Lars Budäus; Thorsten Schlomm; Christian Eichelberg; Roman Heuer; Hans Heinzer; Hartwig Huland; Markus Graefen; fianceeyi chun
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
International journal of radiation oncology, biology, physics 2010;77(3):788-92.
2010: Markus Graefen
Low quality of evidence for robot-assisted laparoscopic prostatectomy: a problem not only in the robotic literature.
European urology 2010;57(6):938-40; discussion 943-4.
2010: Declan G Murphy; Anders Bjartell; Vincenzo Ficarra; Markus Graefen; Alexander Haese; Rodolfo Montironi; Francesco Montorsi; Judd W Moul; Giacomo Novara; Guido Sauter; Tullio Sulser; Henk van der Poel
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications.
European urology 2010;57(5):735-46.
2010: Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; Shahrokh F Shariat; Lars Budaus; Jean-Baptiste Lattouf; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
The Journal of urology 2010;183(4):1324-9.
2010: Giovanni Lughezzani; Lars Budäus; Hendrik Isbarn; Maxine Sun; Paul Perrotte; Alexander Haese; fianceeyi chun; Thorsten Schlomm; Thomas Steuber; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
European urology 2010;57(4):562-8.
2010: Sarah Minner; Birte Jessen; Lars Stiedenroth; Eike Burandt; Jens Köllermann; Martina Mirlacher; Andreas Erbersdobler; Christian Eichelberg; Margit Fisch; Tim H Brümmendorf; Carsten Bokemeyer; Ronald Simon; Thomas Steuber; Markus Graefen; Hartwig Huland; Guido Sauter; Thorsten Schlomm
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1553-60.
2010: Sascha A Ahyai; Hendrik Isbarn; Pierre I Karakiewicz; fianceeyi chun; Mathias Reichert; Jochen Walz; Thomas Steuber; Claudio Jeldres; Thorsten Schlomm; Hans Heinzer; Georg Salomon; Lars Budäus; Paul Perrotte; Hartwig Huland; Markus Graefen; Alexander Haese
The presence of prostate cancer on saturation biopsy can be accurately predicted.
BJU international 2010;105(5):636-41.
2010: Maxine Sun; Giovanni Lughezzani; Ahmed Alasker; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
The Journal of urology 2010;183(3):970-5.
2010: Markus Graefen
The modified Clavien system: a plea for a standardized reporting system for surgical complications.
European urology 2010;57(3):387-9.
2010: Markus Graefen
Editorial comment on: Cost comparison of robotic, laparoscopic and open radical prostatectomy for prostate cancer.
European urology 2010;57(3):458.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Sascha A Ahyai; fianceeyi chun; Claudio Jeldres; Alexander Haese; Hans Heinzer; Mario Zacharias; Roman Heuer; Christian Eichelberg; Thomas Steuber; Lars Budäus; Jens Köllermann; Georg Salomon; Thorsten Schlomm; Paul Perrotte; Margit Fisch; Hartwig Huland; Markus Graefen
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
BJU international 2010;105(6):818-23.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
BJU international 2010;105(6):799-804.
2010: Naeem Bhojani; umberto capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
International journal of radiation oncology, biology, physics 2010;76(2):342-8.
2010: Sara Baillargeon-Gagné; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxime Crépel; Ahmed Alasker; Hugues Widmer; Philippe Arjane; Jean-Jacques Patard; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
BJU international 2010;105(3):359-64.
2010: Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
Urology 2010;75(2):315-20.
2010: Maxime Crépel; Claudio Jeldres; Paul Perrotte; umberto capitanio; Hendrik Isbarn; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Urology 2010;75(2):271-5.
2010: Jochen Walz; Arthur L Burnett; Anthony J Costello; James A Eastham; Markus Graefen; Bertrand Guillonneau; Mani Menon; Francesco Montorsi; Robert P Myers; Bernardo Rocco; Arnauld Villers
A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy.
European urology 2010;57(2):179-92.
2010: Axel Heidenreich; Peter Albers; Johannes Classen; Markus Graefen; Jürgen Gschwend; Jörg Kotzerke; Susanne Krege; Jens Lehmann; Detlef Rohde; Heinz Schmidberger; Michael Uder; Hajo Zeeb
Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.
Urologia internationalis 2010;85(1):1-10.
2010: Alexander T El Gammal; Michael Brüchmann; Jozef Zustin; Hendrik Isbarn; Olaf J C Hellwinkel; Jens Köllermann; Guido Sauter; Ronald Simon; Waldemar Wilczak; Jörg Schwarz; Carsten Bokemeyer; Tim H Brümmendorf; Jakob R Izbicki; Emre F Yekebas; Margit Fisch; Hartwig Huland; Markus Graefen; Thorsten Schlomm
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):56-64.
2010: Thomas Steuber; Thorsten Schlomm; H Heinzer; Mario Zacharias; S Ahyai; K F Chun; Alexander Haese; Susanne Klutmann; Jens Köllermann; G Sauter; Janos Mester; Pal Mikecz; M Fisch; Hartwig Huland; Markus Graefen; Georg Salomon
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
European journal of cancer (Oxford, England : 1990) 2010;46(2):449-55.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Maxine Sun; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Urology 2010;75(1):118-24.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Ahmed Alasker; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3291-7.
2009: Laurent Zini; umberto capitanio; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
BJU international 2009;104(11):1661-7.
2009: Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Hugues Widmer; Philippe Arjane; Daniel Pharand; Margit Fisch; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2009;182(5):2177-81.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Hugues Widmer; Philippe Arjane; Francois Peloquin; Daniel Pharand; Jean-Jacques Patard; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
The Journal of urology 2009;182(4):1287-93.
2009: Maxime Crépel; Hendrik Isbarn; umberto capitanio; Daniel Liberman; Claudio Jeldres; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Urology 2009;74(4):842-5.
2009: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Urology 2009;74(4):858-64.
2009: Claudio Jeldres; Sara Baillargeon-Gagne; Daniel Liberman; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Urology 2009;74(4):837-41.
2009: Hendrik Isbarn; Claudio Jeldres; umberto capitanio; Laurent Zini; Shahrokh F Shariat; Giovanni Lughezzani; Maxine Sun; Sascha A Ahyai; AJ Duclos; Martine Jolivet-Tremblay; Jean-Baptiste Lattouf; Luc Valiquette; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
Journal of endourology / Endourological Society 2009;23(8):1347-52.
2009: Claudio Jeldres; Hendrik Isbarn; umberto capitanio; Laurent Zini; Naeem Bhojani; Shahrokh F Shariat; Vincent Cloutier; Jean-Baptiste Lattouf; AJ Duclos; Martine Jolivet-Tremblay; Luc Valiquette; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
The Journal of urology 2009;182(2):626-32.
2009: Lars Budäus; Hendrik Isbarn; Thorsten Schlomm; Hans Heinzer; Alexander Haese; Thomas Steuber; Georg Salomon; Hartwig Huland; Markus Graefen
Current technique of open intrafascial nerve-sparing retropubic prostatectomy.
European urology 2009;56(2):317-24.
2009: Hendrik Isbarn; Claudio Jeldres; Laurent Zini; Paul Perrotte; Sara Baillargeon-Gagne; umberto capitanio; Shahrokh F Shariat; Phillipe Arjane; Fred Saad; Michael McCormack; Luc Valiquette; Francois Peloquin; AJ Duclos; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
The Journal of urology 2009;182(1):70-7.
2009: Christoph Adam; Georg Salomon; Sebastian Walther; Dirk Zaak; Wael Khoder; Armin Becker; Oliver Reich; Andreas Blana; Roman Ganzer; Stefan Denzinger; Gralf Popken; Ronald Sroka; Ruth Knüchel-Clarke; Jens Köllermann; Guido Sauter; Arndt Hartmann; Simone Bertz; Markus Graefen; Hartwig Huland; Wolf F Wieland; Christian G Stief
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
European urology 2009;55(6):1281-8.
2009: Alberto Briganti; Michael L Blute; James H Eastham; Markus Graefen; Axel Heidenreich; Jeffrey R Karnes; Francesco Montorsi; Urs E Studer
Pelvic lymph node dissection in prostate cancer.
European urology 2009;55(6):1251-65.
2009: Vincenzo Ficarra; Giacomo Novara; Walter Artibani; Andrea Cestari; Antonio Galfano; Markus Graefen; Giorgio Guazzoni; Bertrand Guillonneau; Mani Menon; Francesco Montorsi; Vipul Patel; Jens Rassweiler; Hendrik Van Poppel
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies.
European urology 2009;55(5):1037-63.
2009: Thorsten Schlomm; Olaf J C Hellwinkel; Andreas Buness; Markus Ruschhaupt; Andreas M Lübke; fianceeyi chun; Ronald Simon; Lars Budäus; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Annemarie Poustka; Holger Sültmann
Molecular cancer phenotype in normal prostate tissue.
European urology 2009;55(4):885-90.
2009: Hendrik Isbarn; Claudio Jeldres; Lars Budäus; Georg Salomon; Thorsten Schlomm; Thomas Steuber; fianceeyi chun; Sascha A Ahyai; Umberto Capitanio; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen; Pierre Karakiewicz
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
Urology 2009;73(3):615-9.
2009: Markus Graefen
Editorial comment on: Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging.
European urology 2009;55(3):638.
2009: fianceeyi chun; Nazareno Suardi; umberto capitanio; Claudio Jeldres; Sascha A Ahyai; Markus Graefen; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):617-28-6.
2009: Claudio Jeldres; Nazareno Suardi; Paul Perrotte; umberto capitanio; Jochen Walz; Georg C Hutterer; Fred Saad; Luc Valiquette; Markus Graefen; Hugues Widmer; Pierre I Karakiewicz
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(1):13-21.
2009: Georg Salomon; Hendrik Isbarn; Lars Budaeus; Thorsten Schlomm; Alberto Briganti; Thomas Steuber; Hans Heinzer; Alexander Haese; Markus Graefen; Pierre I Karakiewicz; Hartwig Huland; fianceeyi chun
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
The journal of sexual medicine 2009;6(2):498-504.
2009: Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn M Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 2009;181(2):601-7; discussion 607-8.
2009: Jochen Walz; fianceeyi chun; Eric A Klein; Alwyn M Reuther; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
European urology 2009;55(2):412-19.
2009: N Bhojani; Sascha A Ahyai; Markus Graefen; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2009: Andreas Erbersdobler; Jens Kollermann; Markus Graefen; Christoph Röcken; Thorsten Schlomm
Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer.
BJU international 2009;103(3):324-6.
2009: Hendrik Isbarn; Sascha A Ahyai; fianceeyi chun; Lars Budäus; Thorsten Schlomm; Georg Salomon; Mario Zacharias; Andreas Erbersdobler; Jens Köllermann; Guido Sauter; Hartwig Huland; Markus Graefen; Thomas Steuber
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
European urology 2009;55(2):394-401.
2009: Markus Graefen
Editorial comment on: Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
European urology 2009;55(2):410-1.
2009: Georg Salomon; Thorsten Hess; Andreas Erbersdobler; Christian Eichelberg; Siegfried Greschner; Andrey N Sobchuk; Anna K Korolik; Nicolai A Nemkovich; Jürgen Schreiber; Martin Herms; Markus Graefen; Hartwig Huland
The feasibility of prostate cancer detection by triple spectroscopy.
European urology 2009;55(2):376-83.
2009: Ofer Yossepowitch; Anders Bjartell; James A Eastham; Markus Graefen; Bertrand D Guillonneau; Pierre I Karakiewicz; Rodolfo Montironi; Franceso Montorsi
Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences.
European urology 2009;55(1):87-99.
2008: Achim Fleischmann; Thorsten Schlomm; Hartwig Huland; Jens Köllermann; Philipp Simon; Martina Mirlacher; Georg Salomon; Felix H K Chun; Thomas Steuber; Ronald Simon; Guido Sauter; Markus Graefen; Andreas Erbersdobler
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7838-42.
2008: umberto capitanio; Sascha A Ahyai; Markus Graefen; Claudio Jeldres; Shahrokh F Shariat; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Paul Perrotte; François Péloquin; Daniel Pharand; Philippe Arjane; Hartwig Huland; Pierre I Karakiewicz
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Georg Salomon; Jens Köllerman; Imke Thederan; Felix K-H Chun; Lars Budäus; Thorsten Schlomm; Hendrik Isbarn; Hans Heinzer; Hartwig Huland; Markus Graefen
Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.
European urology 2008;54(6):1354-62.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Georg C Hutterer; Sascha A Ahyai; Jean-Baptiste Lattouf; Alexander Haese; Markus Graefen; Andreas Erbersdobler; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
European urology 2008;54(6):1306-13.
2008: Jochen Walz; Alexander Haese; Vincenzo Scattoni; Thomas Steuber; Felix K-H Chun; Alberto Briganti; Francesco Montorsi; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Cancer 2008;113(10):2695-703.
2008: Nazareno Suardi; umberto capitanio; Felix K-H Chun; Markus Graefen; Paul Perrotte; Thorsten Schlomm; Alexander Haese; Hartwig Huland; Andreas Erbersdobler; Francesco Montorsi; Pierre I Karakiewicz
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
Cancer 2008;113(8):2068-72.
2008: Francesco Montorsi; Gerald Brock; Jay Lee; JoAnn Shapiro; Hendrik Van Poppel; Markus Graefen; Christian Stief
Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy.
European urology 2008;54(4):924-31.
2008: Felix K-H Chun; Alexander Haese; Sascha A Ahyai; Jochen Walz; Nazareno Suardi; umberto capitanio; Markus Graefen; Andreas Erbersdobler; Hartwig Huland; Pierre I Karakiewicz
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
Cancer 2008;113(4):701-9.
2008: Claudio Jeldres; Nazareno Suardi; umberto capitanio; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Francois Peloquin; Daniel Pharand; Markus Graefen; Pierre I Karakiewicz
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
BJU international 2008;102(4):463-7.
2008: Andrea Gallina; Nazareno Suardi; Francesco Montorsi; umberto capitanio; Claudio Jeldres; Fred Saad; Markus Graefen; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; François Péloquin; Paul Perrotte; Pierre I Karakiewicz
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
International journal of cancer. Journal international du cancer 2008;123(3):647-52.
2008: Jochen Walz; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Paul Perrotte; Markus Graefen; Hughes Widmer; Philippe Arjane; Luc Valiquette; Georg C Hutterer; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU international 2008;102(1):33-8.
2008: Claudio Jeldres; Nazareno Suardi; Fred Saad; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Naeem Bhojani; Jochen Walz; Georg C Hutterer; Markus Graefen; Luc Valiquette; Pierre I Karakiewicz
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
European urology 2008;54(1):97-105.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Fred Saad; Georg C Hutterer; Naeem Bhojani; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
European urology 2008;54(1):107-16.
2008: Andrea Gallina; Felix K-H Chun; Nazareno Suardi; James A Eastham; Paul Perrotte; Markus Graefen; Georg C Hutterer; Hartwig Huland; Eric A Klein; Alwyn M Reuther; Francesco Montorsi; Alberto Briganti; Shahrokh F Shariat; Claus G Roehrborn; Alexandre de la Taille; Laurent Salomon; Pierre I Karakiewicz
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Olaf J C Hellwinkel; Jan-Peer Rogmann; Legrehndem E Asong; Andreas M Luebke; Christian Eichelberg; Sascha Ahyai; Hendrik Isbarn; Markus Graefen; Hartwig Huland; Thorsten Schlomm
A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.
BJU international 2008;101(11):1454-60.
2008: Pierre I Karakiewicz; Naeem Bhojani; Alfred I Neugut; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Paul Perrotte; Francois Peloquin; Michael W Kattan
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Jochen Walz; Francesco Montorsi; Claudio Jeldres; Nazareno Suardi; Shahrokh F Shariat; Paul Perrotte; Philippe Arjane; Markus Graefen; Daniel Pharand; Pierre I Karakiewicz
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
BJU international 2008;101(7):826-32.
2008: Sascha A Ahyai; Markus Graefen; Thomas Steuber; Alexander Haese; Thorsten Schlomm; Jochen Walz; Jens Köllermann; Alberto Briganti; Mario Zacharias; Martin G Friedrich; Pierre I Karakiewicz; Francesco Montorsi; Hartwig Huland; Felix K-H Chun
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
European urology 2008;53(4):750-7.
2008: Nazareno Suardi; Christopher R Porter; Alwyn M Reuther; Jochen Walz; Koichi Kodama; Robert P Gibbons; Roy Correa; Francesco Montorsi; Markus Graefen; Hartwig Huland; Eric A Klein; Pierre I Karakiewicz
A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Cancer 2008;112(6):1254-63.
2008: Markus Graefen
Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
European urology 2008;53(3):664-5.
2008: Pierre I Karakiewicz; Felix K-H Chun; Andrea Gallina; Nazareno Suardi; Alberto Briganti; Andreas Erbersdobler; Thorsten Schlomm; Jochen Walz; Eike Currlin; Uwe Michl; Alexander Haese; Philippe Arjane; Hans Heinzer; Markus Graefen; Hartwig Huland
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
Journal of endourology / Endourological Society 2008;22(3):533-8.
2008: Markus Graefen; S Ahyai; R Heuer; Georg Salomon; Thorsten Schlomm; H Isbarn; L Budäus; H Heinzer; Hartwig Huland
[Active surveillance for prostate cancer].
Der Urologe. Ausg. A 2008;47(3):261-9.
2008: Alberto Briganti; Andrea Gallina; Nazareno Suardi; Felix K-H Chun; Jochen Walz; Roman Heuer; Andrea Salonia; Alexander Haese; Paul Perrotte; Luc Valiquette; Markus Graefen; Patrizio Rigatti; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
BJU international 2008;101(5):556-60.
2008: Jochen Walz; Nazareno Suardi; Georg C Hutterer; Paul Perrotte; Andrea Gallina; Francois Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
Journal of endourology / Endourological Society 2008;22(2):369-76.
2008: Jochen Walz; Paul Perrotte; Nazareno Suardi; Georg C Hutterer; Claudio Jeldres; François Bénard; Luc Valiquette; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
The journal of sexual medicine 2008;5(2):428-35.
2008: Thorsten Schlomm; Esther Näkel; Andreas Lübke; Andreas Buness; Felix K-H Chun; Thomas Steuber; Markus Graefen; Ronald Simon; Guido Sauter; Annemarie Poustka; Hartwig Huland; Andreas Erbersdobler; Holger Sültmann; Olaf J C Hellwinkel
Marked gene transcript level alterations occur early during radical prostatectomy.
European urology 2008;53(2):333-44.
2007: Alberto Briganti; Felix K-H Chun; Nazareno Suardi; Andrea Gallina; Jochen Walz; Markus Graefen; Shahrokh F Shariat; Andreas Ebersdobler; Patrizio Rigatti; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Andrea Gallina; Alberto Briganti; Felix K-H Chun; Jochen Walz; Georg C Hutterer; Andreas Erbersdobler; Christian Eichelberg; Thorsten Schlomm; Sascha A Ahyai; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU international 2007;100(6):1249-53.
2007: Thorsten Schlomm; Patrick Kirstein; Liv Iwers; Birte Daniel; Thomas Steuber; Jochen Walz; fianceeyi chun; Alexander Haese; Jens Kollermann; Markus Graefen; Hartwig Huland; Guido Sauter; Ronald Simon; Andreas Erbersdobler
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6579-84.
2007: Markus Graefen
Is the open retropubic radical prostatectomy dead?
European urology 2007;52(5):1281-3.
2007: Andrea Gallina; Claudio Jeldres; Felix K-H Chun; Shahrokh F Shariat; Alberto Briganti; Jochen Walz; Claus G Roehrborn; Fred Saad; Hartwig Huland; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
European urology 2007;52(5):1374-80.
2007: Felix K-H Chun; Alberto Briganti; Andrea Gallina; Georg C Hutterer; Shahrokh F Shariat; Elie Antebie; Jochen Walz; Claus G Roehrborn; Andrea Salonia; Patrizio Rigatti; Fred Saad; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
European urology 2007;52(4):1067-74.
2007: Jochen Walz; Andrea Gallina; Georg C Hutterer; Paul Perrotte; Shahrokh F Shariat; Markus Graefen; Michael McCormack; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;69(1):88-94.
2007: Alberto Briganti; Felix K-H Chun; Georg C Hutterer; Andrea Gallina; Shahrokh F Shariat; Andrea Salonia; Vincenzo Scattoni; Luc Valiquette; Francesco Montorsi; Patrizio Rigatti; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
European urology 2007;52(3):733-43.
2007: Jochen Walz; Andrea Gallina; Fred Saad; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3576-81.
2007: Andrea Gallina; Pierre I Karakiewicz; Georg C Hutterer; Felix K-H Chun; Alberto Briganti; Jochen Walz; Elie Antebi; Shahrokh F Shariat; Nazareno Suardi; Markus Graefen; Andreas Erbersdobler; Andrea Salonia; Patrizio Rigatti; Hartwig Huland; Francesco Montorsi
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
International journal of cancer. Journal international du cancer 2007;121(4):791-5.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Francesco Montorsi; Christopher Porter; Vincenzo Scattoni; Andrea Gallina; Jochen Walz; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Thorsten Schlomm; Sascha A Ahyai; Eike Currlin; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended 10-core biopsy nomogram.
European urology 2007;52(2):436-44.
2007: Dirk Rades; Rudolf Schwarz; Manuel Todorovic; Horst Thurmann; Markus Graefen; Jochen Walz; Steven E Schild; Jürgen Dunst; Winfried Alberti
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(7):398-402.
2007: Andrea Gallina; Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Francesco Montorsi; Andrea Salonia; Andreas Erbersdobler; Patrizio Rigatti; Luc Valiquette; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
European urology 2007;52(1):98-105.
2007: Andrea Gallina; Pierre I Karakiewicz; Felix K-H Chun; Alberto Briganti; Markus Graefen; Francesco Montorsi; Jochen Walz; Claudio Jeldres; Andreas Erbersdobler; Andrea Salonia; Nazareno Suardi; Federico Dehò; Thorsten Schlomm; Vincenzo Scattoni; Alexander Haese; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Hartwig Huland
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
BJU international 2007;99(6):1404-8.
2007: Alberto Briganti; Pierre I Karakiewicz; Felix K-H Chun; Andrea Gallina; Andrea Salonia; Giuseppe Zanni; Luc Valiquette; Markus Graefen; Hartwig Huland; Patrizio Rigatti; Francesco Montorsi
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
European urology 2007;51(6):1573-81.
2007: Jörg Kotzerke; Klaus Zöphel; Georg Salomon; Markus Graefen; Axel Heidenreich
[Pro and contra: 11C choline PET in diagnosis of prostate cancer].
Aktuelle Urologie 2007;38(3):189-94.
2007: Georg C Hutterer; Paul Perrotte; Andrea Gallina; Jochen Walz; Claudio Jeldres; Miriam Traumann; Nazareno Suardi; Fred Saad; François Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
European journal of cancer (Oxford, England : 1990) 2007;43(7):1180-7.
2007: Felix K-H Chun; Markus Graefen; Alberto Briganti; Andrea Gallina; Julia Hopp; Michael W Kattan; Hartwig Huland; Pierre I Karakiewicz
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
European urology 2007;51(5):1236-40; discussion 1241-3.
2007: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Jochen Walz; Michael W Kattan; Hartwig Huland; Markus Graefen
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
BJU international 2007;99(4):794-800.
2007: Alberto Briganti; Andrea Salonia; Andrea Gallina; Felix K-H Chun; Pierre I Karakiewicz; Markus Graefen; Hartwig Huland; Patrizio Rigatti; Francesco Montorsi
Management of erectile dysfunction after radical prostatectomy in 2007.
World journal of urology 2007;25(2):143-8.
2007: Felix K-H Chun; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen
Role of nomograms for prostate cancer in 2007.
World journal of urology 2007;25(2):131-42.
2007: Rudolf Schwarz; Markus Graefen; Andreas Krüll
Therapy of recurrent disease after radical prostatectomy in 2007.
World journal of urology 2007;25(2):161-7.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Thomas Steuber; Andrea Gallina; Jochen Walz; Paul Perrotte; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
European urology 2007;51(4):949-55; discussion 955.
2007: Carsten Stephan; Chuanliang Xu; Henning Cammann; Markus Graefen; Alexander Haese; Hartwig Huland; Axel Semjonow; Eleftherios P Diamandis; Mesut Remzi; Bob Djavan; Mark F Wildhagen; Bert G Blijenberg; Patrik Finne; Ulf-Hakan Stenman; Klaus Jung; Hellmuth-Alexander Meyer
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
World journal of urology 2007;25(1):95-103.
2007: Jochen Walz; Markus Graefen; Hartwig Huland
Basic principles of anatomy for optimal surgical treatment of prostate cancer.
World journal of urology 2007;25(1):31-8.
2007: Jochen Walz; Markus Graefen; Uwe Michl; Hans Heinzer; M G Friedrich; Christian Eichelberg; Alexander Haese; Hartwig Huland
[Technical aspects of nerve sparing during retropubic prostatectomy].
Annales d'urologie 2007;41(1):23-30.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Christopher Porter; Francesco Montorsi; Alexander Haese; Vincenzo Scattoni; Lester Borden; Thomas Steuber; Andrea Salonia; Thorsten Schlomm; Kalyan Latchemsetty; Jochen Walz; Jason Kim; Christian Eichelberg; Eike Currlin; Sascha A Ahyai; Andreas Erbersdobler; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended repeat biopsy nomogram.
The Journal of urology 2007;177(2):510-5.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andrea Gallina; Andreas Erbersdobler; Thorsten Schlomm; Jochen Walz; Christian Eichelberg; Georg Salomon; Alexander Haese; Eike Currlin; Sascha A Ahyai; François Bénard; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(3):536-43.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Andreas Erbersdobler; Jochen Walz; Thorsten Schlomm; Mirja Meschke; Alexander Haese; Luc Valiquette; Hartwig Huland; Pierre I Karakiewicz
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(2):375-82.
2007: Christian Eichelberg; Andreas Erbersdobler; Uwe Michl; Thorsten Schlomm; Georg Salomon; Markus Graefen; Hartwig Huland
Nerve distribution along the prostatic capsule.
European urology 2007;51(1):105-10; discussion 110-1.
2006: Thomas Steuber; Felix K-H Chun; Andreas Erbersdobler; Alberto Briganti; Alexander Haese; Markus Graefen; Thorsten Schlomm; Luc Valiquette; Hartwig Huland; Pierre I Karakiewicz
Development and internal validation of preoperative transition zone prostate cancer nomogram.
Urology 2006;68(6):1295-300.
2006: Felix K-H Chun; Alberto Briganti; Elie Antebi; Markus Graefen; Eike Currlin; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Alexander Haese; Martin G Friedrich; Sascha A Ahyai; Christian Eichelberg; Georg Salomon; Andrea Gallina; Andreas Erbersdobler; Paul Perrotte; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
BJU international 2006;98(6):1204-9.
2006: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Andrea Gallina; Michael W Kattan; Francesco Montorsi; Hartwig Huland; Markus Graefen
Prostate cancer nomograms: an update.
European urology 2006;50(5):914-26; discussion 926.
2006: Christof Börgermann; M Sieverding; P Fornara; Markus Graefen; Peter Hammerer; A Semjonow; F Schröder; Herbert Rübben
[PSA 2010--the beginning of a new era in early detection of prostate cancer].
Der Urologe. Ausg. A 2006;45 Suppl 4():127-33.
2006: Felix K-H Chun; Imke Müller; Imke Lange; Martin G Friedrich; Andreas Erbersdobler; Pierre I Karakiewicz; Markus Graefen; Klaus Pantel; Hartwig Huland; Heidi Schwarzenbach
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
BJU international 2006;98(3):544-8.
2006: Jochen Walz; Markus Graefen; Felix K-H Chun; Andreas Erbersdobler; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Hartwig Huland; Pierre I Karakiewicz
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
European urology 2006;50(3):498-505.
2006: Markus Graefen
In which patients with prostate cancer should we perform a lymph-node dissection?
European urology 2006;50(2):278-9; author reply 279.
2006: Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Markus Graefen; Francesco Montorsi; Andreas Erbersdobler; Thomas Steuber; Andrea Salonia; Eike Currlin; Vincenzo Scattoni; Martin G Friedrich; Thorsten Schlomm; Alexander Haese; Uwe Michl; Renzo Colombo; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Claus G Roehrborn; Hartwig Huland; Pierre I Karakiewicz
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Markus Graefen
The positive surgical margin after radical prostatectomy--why do we still not really know what it means?
European urology 2006;50(2):199-201.
2006: Felix K-H Chun; Markus Graefen; Mario Zacharias; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Pierre I Karakiewicz; Hartwig Huland
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World journal of urology 2006;24(3):273-80.
2006: Uwe Michl; Martin G Friedrich; Markus Graefen; Alexander Haese; Hans Heinzer; Hartwig Huland
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.
The Journal of urology 2006;176(1):227-31.
2006: Alvaro Ramirez; Serge Benayoun; Alberto Briganti; Jongi Chun; Paul Perrotte; Michael W Kattan; Markus Graefen; Michael McCormack; Alfred I Neugut; Fred Saad; Pierre I Karakiewicz
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
European urology 2006;50(1):58-62; discussion 62-3.
2006: Christian Eichelberg; Andreas Erbersdobler; Alexander Haese; Thorsten Schlomm; Felix K-H Chun; Eike Currlin; Jochen Walz; Thomas Steuber; Markus Graefen; Hartwig Huland
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.
European urology 2006;49(6):1011-6; discussion 1016-8.
2006: Felix K-H Chun; Thomas Steuber; Andreas Erbersdobler; Eike Currlin; Jochen Walz; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Michael McCormack; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
European urology 2006;49(5):820-6.
2006: Pierre I Karakiewicz; Felix K-H Chun; Alberto Briganti; Paul Perrotte; Michael McCormack; François Bénard; Luc Valiquette; Markus Graefen; Fred Saad
Prostate cancer nomograms are superior to neural networks.
The Canadian journal of urology 2006;13 Suppl 2():18-25.
2006: Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
The Journal of urology 2006;175(3 Pt 1):939-44; discussion 944.
2006: Thomas Steuber; Andreas Erbersdobler; Markus Graefen; Alexander Haese; Hartwig Huland; Pierre I Karakiewicz
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
Cancer 2006;106(4):775-82.
2006: Felix K-H Chun; Alberto Briganti; Thierry Lebeau; Vincent Fradet; Thomas Steuber; Jochen Walz; Thorsten Schlomm; Christian Eichelberg; Alexander Haese; Andreas Erbersdobler; Michael McCormack; Paul Perrotte; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
European urology 2006;49(2):273-8; discussion 278-9.
2006: Martin G Friedrich; E Friedrich; Markus Graefen; Hans Heinzer; Uwe Michl; Hartwig Huland; Joachim Noldus
[Success rates of two-layer, microsurgical vasovasostomy. Results from a patient questionnaire and comparison with one-layer technique].
Aktuelle Urologie 2006;37(1):58-63.
2006: Markus Graefen; Jochen Walz; Hartwig Huland
Open retropubic nerve-sparing radical prostatectomy.
European urology 2006;49(1):38-48.
2005: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Michael Lein; Axel Semjonow; Markus Graefen; Maciej Kwiatkowski; Claudia Abramjuk; Carsten Stephan; Alexander Haese; fianceeyi chun; Dietmar Schnorr; Stefan A Loening; Klaus Jung
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigen.
The Journal of urology 2005;174(6):2150-3.
2005: Markus Graefen; Georg Salomon; Eike Currlin; Christian Eichelberg; Thorsten Schlomm; Hartwig Huland
[Selection criteria for the expected management of localised prostate cancer].
Der Urologe. Ausg. A 2005;44(11):1277-8, 1280-6.
2005: Thorsten Schlomm; Andreas M Luebke; Holger Sültmann; Olaf J C Hellwinkel; Ulrich Sauer; Annemarie Poustka; Kerstin A David; Felix K-H Chun; Alexander Haese; Markus Graefen; Andreas Erbersdobler; Hartwig Huland
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
International journal of oncology 2005;27(3):713-20.
2005: Markus Graefen; Jochen Walz; K-H F Chun; Thorsten Schlomm; Alexander Haese; Hartwig Huland
Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
European urology 2005;47(6):756-60.
2005: Pierre I Karakiewicz; Serge Benayoun; Michael W Kattan; Paul Perrotte; Luc Valiquette; Peter T Scardino; Ilias Cagiannos; Hans Heinzer; Simon Tanguay; Armen G Aprikian; Hartwig Huland; Markus Graefen
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Anoop M Meraney; Alexander Haese; Jüri Palisaar; Markus Graefen; Thomas Steuber; Hartwig Huland; Eric A Klein
Surgical management of prostate cancer: advances based on a rational approach to the data.
European journal of cancer (Oxford, England : 1990) 2005;41(6):888-907.
2005: Thomas Steuber; Pauliina Niemela; Alexander Haese; Kim Pettersson; Andreas Erbersdobler; K-H Felix Chun; Markus Graefen; Michael W Kattan; Hartwig Huland; Hans Lilja
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
The Prostate 2005;63(1):13-8.
2005: Thomas Steuber; Pierre I Karakiewicz; Herbert Augustin; Andreas Erbersdobler; Imke Lange; Alexander Haese; K-H F Chun; Jochen Walz; Markus Graefen; Hartwig Huland
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
The Journal of urology 2005;173(3):737-41.
2005: Rein-Jüri Palisaar; Joachim Noldus; Markus Graefen; Andreas Erbersdobler; Alexander Haese; Hartwig Huland
Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
European urology 2005;47(2):176-84.
2004: Herbert Augustin; Andreas Erbersdobler; Peter Hammerer; Markus Graefen; Hartwig Huland
Prostate cancers in the transition zone: Part 2; clinical aspects.
BJU international 2004;94(9):1226-9.
2004: Markus Graefen
[Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer--a multi-institutional update].
Aktuelle Urologie 2004;35(5):377-8.
2004: Alexander Haese; Markus Graefen; Hartwig Huland; Hans Lilja
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Current urology reports 2004;5(3):231-40.
2004: Peter Hammerer; Herbert Augustin; Jakob Blonski; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Fedor Daghofer; Hartwig Huland
[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system].
Der Urologe. Ausg. A 2004;43(3):307-12.
2004: Ilias Cagiannos; Pierre I Karakiewicz; Markus Graefen; James A Eastham; Makoto Ohori; Farhang Rabbani; Victor E Reuter; Thomas Wheeler; Patrick A Kupelian; Eric Klein; Hartwig Huland; Peter Hammerer; Andreas Erbersdobler; Fritz Schroeder; Mark F Wildhagen; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Uwe Michl; D Lange; Markus Graefen; Hartwig Huland
Re: Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. C. P. Nelson, J. E. Montie, E. J. McGuire, G. Wedemeyer and J.T. Wei. J Urol, 169: 2225-2228, 2003.
The Journal of urology 2004;171(1):359; author reply 359.
2004: Markus Graefen; Makoto Ohori; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland; Thomas M Wheeler; Kevin Slawin; Peter T Scardino; Michael W Kattan
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2004: Herbert Augustin; Thilo Eggert; Sven Wenske; Pierre I Karakiewicz; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Markus Graefen
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
The Journal of urology 2004;171(1):177-81.
2003: Alexander Haese; Markus Graefen; Thomas Steuber; Charlotte Becker; Joachim Noldus; Andreas Erbersdobler; Edith Huland; Hartwig Huland; Hans Lilja
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
The Journal of urology 2003;170(6 Pt 1):2269-73.
2003: Ilias Cagiannos; Pierre I Karakiewicz; James A Eastham; Makoto Ohori; Farhang Rabbani; Claudia Gerigk; Victor E Reuter; Markus Graefen; Peter Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick A Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Michael W Kattan; James A Eastham; Thomas M Wheeler; Norio Maru; Peter T Scardino; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Hideshige Koh; Shahrokh F Shariat; Kevin Slawin; Makoto Ohori
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Herbert Augustin; Peter Hammerer; Markus Graefen; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Andreas Erbersdobler
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy.
Journal of cancer research and clinical oncology 2003;129(11):662-8.
2003: Uwe Michl; Markus Graefen; Joachim Noldus; T Eggert; Hartwig Huland
[Functional results of various surgical techniques for radical prostatectomy].
Der Urologe. Ausg. A 2003;42(9):1196-202.
2003: Jüri Palisaar; T Eggert; Markus Graefen; Alexander Haese; Hartwig Huland
[Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications].
Der Urologe. Ausg. A 2003;42(9):1188-95.
2003: Alexander Haese; Markus Graefen; Jüri Palisaar; Edith Huland; Hartwig Huland
[Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
Der Urologe. Ausg. A 2003;42(9):1172-87.
2003: Herbert Augustin; Markus Graefen; Jüri Palisaar; Jakob Blonski; Andreas Erbersdobler; Fedor Daghofer; Hartwig Huland; Peter Hammerer
Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2860-8.
2003: Herbert Augustin; Peter Hammerer; Jakob Blonski; Markus Graefen; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Andreas Erbersdobler
Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?
Urology 2003;62(1):79-85.
2003: Michael Aleman; Pierre I Karakiewicz; Patrick A Kupelian; Michael W Kattan; Markus Graefen; Ilias Cagiannos; James A Eastham; Peter T Scardino; Hartwig Huland; Eric A Klein
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Markus Graefen; Herbert Augustin; P I Karakiewicz; Peter Hammerer; Alexander Haese; Jüri Palisaar; S Fernandez; Joachim Noldus; Andreas Erbersdobler; Ilias Cagiannos; Peter T Scardino; Michael W Kattan; Hartwig Huland
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
Der Urologe. Ausg. A 2003;42(5):685-92.
2003: Herbert Augustin; Peter Hammerer; Markus Graefen; Andreas Erbersdobler; Jakob Blonski; Jüri Palisaar; Fedor Daghofer; Hartwig Huland
Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.
European urology 2003;43(5):455-60.
2003: Herbert Augustin; Andreas Erbersdobler; Markus Graefen; T Jaekel; Alexander Haese; Hartwig Huland; Peter Hammerer
Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
BJU international 2003;91(6):477-81.
2003: Herbert Augustin; Andreas Erbersdobler; Markus Graefen; Salvador Fernandez; Jüri Palisaar; Hartwig Huland; Peter Hammerer
Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
The Prostate 2003;55(1):48-54.
2003: Alexander Haese; Manisha Chaudhari; M Craig Miller; Jonathan I Epstein; Hartwig Huland; Jüri Palisaar; Markus Graefen; Peter Hammerer; Edward C Poole; Gerard J O'Dowd; Alan W Partin; Robert W Veltri
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
Cancer 2003;97(4):969-78.
2003: Alexander Haese; Markus Graefen; Charlotte Becker; Joachim Noldus; Jared Katz; Ilias Cagiannos; Michael W Kattan; Peter T Scardino; Edith Huland; Hartwig Huland; Hans Lilja
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
2003: Herbert Augustin; Peter Hammerer; Markus Graefen; Jüri Palisaar; Joachim Noldus; Salvador Fernandez; Hartwig Huland
Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002.
European urology 2003;43(2):113-8.
2003: Markus Graefen; Herbert Augustin; Pierre I Karakiewicz; Peter Hammerer; Alexander Haese; Jüri Palisaar; Jakob Blonski; Salvador Fernandez; Andreas Erbersdobler; Hartwig Huland
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
European urology 2003;43(1):6-10; discussion 11.
2002: Joachim Noldus; Markus Graefen; Hartwig Huland
Major postoperative complications secondary to use of the Bookwalter self-retaining retractor.
Urology 2002;60(6):964-7.
2002: Thomas Steuber; Paulina Nurmikko; Alexander Haese; Kim Pettersson; Markus Graefen; Peter Hammerer; Hartwig Huland; Hans Lilja
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
The Journal of urology 2002;168(5):1917-22.
2002: Joachim Noldus; Uwe Michl; Markus Graefen; Alexander Haese; Peter Hammerer; Hartwig Huland
Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.
European urology 2002;42(2):118-24.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick A Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard H Bochner; Hartwig Huland; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo Van der Kwast; Peter T Scardino; Michael W Kattan
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Martin G Friedrich; Angelika Hellstern; Stefan H Hautmann; Markus Graefen; Stefan Conrad; Edith Huland; Hartwig Huland
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
The Journal of urology 2002;168(2):470-4.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Salvador Fernandez; Jochen Noldus; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Ilias Cagiannos; Markus Graefen; Pierre I Karakiewicz; Makoto Ohori; James A Eastham; Farhang Rabbani; William Fair; Thomas M Wheeler; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Edith Huland; Peter T Scardino; Michael W Kattan; Hartwig Huland
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Eric Klein; Patrick A Kupelian; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Peter T Scardino; Michael W Kattan
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
2002: Hartwig Huland; Markus Graefen; Alexander Haese; Peter Hammerer; Jüri Palisaar; Uwe Pichlmeier; Rolf-Peter Henke; Andreas Erbersdobler; Edith Huland; Hans Lilja
Prediction of tumor heterogeneity in localized prostate cancer.
The Urologic clinics of North America 2002;29(1):213-22.
2002: R Jüri Palisaar; Markus Graefen; Pierre I Karakiewicz; Peter Hammerer; Edith Huland; Alexander Haese; Salvador Fernandez; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
European urology 2002;41(2):155-61.
2002: Stefan Conrad; Markus Graefen; Uwe Pichlmeier; Rolf-Peter Henke; Andreas Erbersdobler; Peter Hammerer; Hartwig Huland
Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.
The Journal of urology 2002;167(2 Pt 1):521-5.
2002: Andreas Erbersdobler; S Huhle; Jüri Palisaar; Markus Graefen; Peter Hammerer; Joachim Noldus; Hartwig Huland
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone.
Prostate cancer and prostatic diseases 2002;5(4):279-84.
2002: Andreas Erbersdobler; Henning Fritz; Silvia Schnöger; Markus Graefen; Peter Hammerer; Hartwig Huland; Rolf-Peter Henke
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
European urology 2002;41(1):40-6.
2001: Alexander Haese; Markus Graefen; Thomas Steuber; Charlotte Becker; Kim Pettersson; Timo Piironen; Joachim Noldus; Hartwig Huland; Hans Lilja
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
The Prostate 2001;49(2):101-9.
2001: W Prange; Andreas Erbersdobler; Peter Hammerer; Markus Graefen; Stefan H Hautmann; RE Hautmann; Hartwig Huland; Rolf-Peter Henke
High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens.
European urology 2001;39 Suppl 4():30-1.
2001: Stefan Conrad; Stefan H Hautmann; Rolf-Peter Henke; Andreas Erbersdobler; J Simon; M Straub; Markus Graefen; RE Hautmann; Hartwig Huland
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients.
European urology 2001;39 Suppl 4():25-9.
2001: Joachim Noldus; Uwe Michl; Markus Graefen; Alexander Haese; Peter Hammerer; S Fernandez; Hartwig Huland
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey].
Der Urologe. Ausg. A 2001;40(2):102-6.
2001: W Prange; Andreas Erbersdobler; Peter Hammerer; Markus Graefen; Stefan H Hautmann; RE Hautmann; Hartwig Huland; Rolf-Peter Henke
Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens.
Urology 2001;57(3):486-90.
2001: Markus Graefen; Alexander Haese; Uwe Pichlmeier; Peter Hammerer; Joachim Noldus; K Butz; Andreas Erbersdobler; Rolf-Peter Henke; Uwe Michl; S Fernandez; Hartwig Huland
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
The Journal of urology 2001;165(3):857-63.
2000: Peter Hammerer; Markus Graefen; Rolf-Peter Henke; Alexander Haese; Jüri Palisaar; Edith Huland; Hartwig Huland
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy.
Anticancer research 2000;20(6D):5253-5.
2000: C Reek; Markus Graefen; Andreas Erbersdobler; Alexander Haese
[Mucinous adenocarcinoma of the urachus. Case report and review of the literature].
Der Urologe. Ausg. A 2000;39(6):572-5.
2000: Peter Hammerer; Markus Graefen; Thomas Steuber; Hartwig Huland
[Chemoprevention of prostatic carcinoma].
Der Urologe. Ausg. A 2000;39(4):304-8.
2000: Joachim Noldus; Markus Graefen; Alexander Haese; Rolf-Peter Henke; Peter Hammerer; Hartwig Huland
Stage migration in clinically localized prostate cancer.
European urology 2000;38(1):74-8.
2000: Stefan H Hautmann; Stefan Conrad; Rolf-Peter Henke; Andreas Erbersdobler; J Simon; M Straub; Markus Graefen; RE Hautmann; Hartwig Huland
Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
The Journal of urology 2000;163(6):1734-8.
2000: Markus Graefen; Peter Hammerer; Alexander Haese; Hartwig Huland
[Therapeutic options in hormone refractory prostate carcinoma].
Der Urologe. Ausg. A 2000;39(3):267-73.
2000: Alexander Haese; Charlotte Becker; Joachim Noldus; Markus Graefen; Edith Huland; Hartwig Huland; Hans Lilja
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
The Journal of urology 2000;163(5):1491-7.
2000: C Reek; Markus Graefen; J Noldus; S Fernandez
[Mixed squamous epithelial and adenocarcinoma of the female urethra. A case report].
Der Urologe. Ausg. A 2000;39(2):174-7.
1999: Alexander Haese; Edith Huland; Markus Graefen; Hartwig Huland
Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
Anticancer research 1999;19(4A):2641-4.
1999: Alexander Haese; Edith Huland; Markus Graefen; P Hammerer; Joachim Noldus; Hartwig Huland
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
The Journal of urology 1999;161(4):1206-11.
1999: Markus Graefen; Joachim Noldus; Uwe Pichlmeier; A Haese; P Hammerer; Salvador Fernandez; S Conrad; Rolf-Peter Henke; Edith Huland; Hartwig Huland
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
European urology 1999;36(1):21-30.
1998: Rolf-Peter Henke; Peter Hammerer; Markus Graefen; Andreas Erbersdobler; M Neumann; J Berger; Hartwig Huland
Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma.
Cancer 1998;83(5):977-88.
1998: Stefan Conrad; Markus Graefen; Uwe Pichlmeier; Rolf-Peter Henke; Peter Hammerer; Hartwig Huland
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma.
The Journal of urology 1998;159(6):2023-9.
1998: Joachim Noldus; Markus Graefen; Edith Huland; C Busch; P Hammerer; Hartwig Huland
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer.
The Journal of urology 1998;159(6):2004-7; discussion 2007-8.
1998: I Lange; Peter Hammerer; Cornelius Knabbe; Markus Graefen; M Schmahl; Hartwig Huland
[Plasma TGF-beta1 concentrations in patients with prostate carcinoma or benign prostatic hyperplasia].
Der Urologe. Ausg. A 1998;37(2):199-202.
1998: Joachim Noldus; Markus Graefen; Peter Hammerer; Rolf-Peter Henke; Hartwig Huland
[Development of tumor selection based on pathological stage in clinically localized prostate carcinoma].
Der Urologe. Ausg. A 1998;37(2):195-8.
1998: Markus Graefen; Peter Hammerer; Uwe Michl; Joachim Noldus; Alexander Haese; Rolf-Peter Henke; Edith Huland; Hartwig Huland
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy.
Urology 1998;51(3):437-42.
1998: Hans Heinzer; Peter Hammerer; Markus Graefen; Hartwig Huland
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas.
European urology 1998;33(1):86-90.
1997: Alexander Haese; Markus Graefen; Joachim Noldus; P Hammerer; Edith Huland; Hartwig Huland
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
The Journal of urology 1997;158(6):2188-92.
1997: Joachim Noldus; Peter Hammerer; Markus Graefen; Hartwig Huland
Surgical therapy for localized prostatic carcinoma.
Journal of cancer research and clinical oncology 1997;123(3):180-4.